Live Breaking News & Updates on Fierce Pharma

Stay updated with breaking news from Fierce pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASCO: With first-in-class win, Sanofi's Sarclisa looks to step out of J&J's multiple myeloma shadow

ASCO: With first-in-class win, Sanofi's Sarclisa looks to step out of J&J's multiple myeloma shadow
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Germany , German , Bristol-myers-squibb-revlimid , Takeda-velcade , Jj-darzalex-faspro , Peter-adamson , Johnson-darzalex , Amgen-kyprolis , Adamson , Bristol-myers-squibb , Fierce-pharma ,

BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention

BlueSphere Bio to Present Corporate Update and Participate in a Panel Discussion at the 2024 BIO International Convention
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-diego-convention-center , California , United-states , San-diego , Angus-liu , Kim-jaffe , Bluesphere-bio , Andrew-mielach , Keir-loiacono , Lifesci-communications , Panel-discussion , Head-of-business-development-strategy

Novartis' ASCO booth uses AR to simulate patient burden

Novartis' ASCO booth uses AR to simulate patient burden
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-states , Chicago , Illinois , American , Gail-horwood , Las-vegas , American-society-of-clinical-oncology , Novartis , Big-pharma , American-society , Clinical-oncology , Fierce-pharma

ASCO: Bristol Myers unveils I-O triplet data in melanoma as Iovance touts 'paradigm-changing' combo result

Over the years, melanoma has become a popular testing ground for researchers to explore new immuno-oncology approaches. ....

United-states , American , Graf-finckenstein , Friedrich-graf-finckenstein , Bristol-opdivo , Merck-co , American-society-of-clinical-oncology , Bristol-myers-squibb , Bristol-myer , American-society , Clinical-oncology , Leerink-partners

ASCO: Merck KGaA's Bavencio combo misses survival mark in RCC

Although the overall survival miss won't cost Bavencio its FDA approval, it puts the drug further behind rival PD-1 combos from Merck & Co. and BMS. ....

New-york , United-states , American , Merck-keytruda , Keytruda-lenvima , Peter-guenter , Exelixi-cabometyx , Merck-kgaa-bavencio , International-metastatic , Merck-kgaa , Bristol-myers-squibb , Pfizer